BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 26784176)

  • 21. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.
    Macha MA; Rachagani S; Qazi AK; Jahan R; Gupta S; Patel A; Seshacharyulu P; Lin C; Li S; Wang S; Verma V; Kishida S; Kishida M; Nakamura N; Kibe T; Lydiatt WM; Smith RB; Ganti AK; Jones DT; Batra SK; Jain M
    Oncotarget; 2017 Mar; 8(13):20961-20973. PubMed ID: 28423495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of metabolism in cancer cell radioresistance and radiosensitization methods.
    Tang L; Wei F; Wu Y; He Y; Shi L; Xiong F; Gong Z; Guo C; Li X; Deng H; Cao K; Zhou M; Xiang B; Li X; Li Y; Li G; Xiong W; Zeng Z
    J Exp Clin Cancer Res; 2018 Apr; 37(1):87. PubMed ID: 29688867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
    Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
    Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA double strand break repair inhibition as a cause of heat radiosensitization: re-evaluation considering backup pathways of NHEJ.
    Iliakis G; Wu W; Wang M
    Int J Hyperthermia; 2008 Feb; 24(1):17-29. PubMed ID: 18214766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma.
    Harada T; Harada K; Ueyama Y
    Int J Oncol; 2012 Aug; 41(2):565-72. PubMed ID: 22664937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Natural Radiosensitizers and Cancer Cell Radioresistance: An Update.
    Malik A; Sultana M; Qazi A; Qazi MH; Parveen G; Waquar S; Ashraf AB; Rasool M
    Anal Cell Pathol (Amst); 2016; 2016():6146595. PubMed ID: 26998418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular targets that sensitize cancer to radiation killing: From the bench to the bedside.
    Sriramulu S; Thoidingjam S; Brown SL; Siddiqui F; Movsas B; Nyati S
    Biomed Pharmacother; 2023 Feb; 158():114126. PubMed ID: 36521246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The novel chemical entity YTR107 inhibits recruitment of nucleophosmin to sites of DNA damage, suppressing repair of DNA double-strand breaks and enhancing radiosensitization.
    Sekhar KR; Reddy YT; Reddy PN; Crooks PA; Venkateswaran A; McDonald WH; Geng L; Sasi S; Van Der Waal RP; Roti JL; Salleng KJ; Rachakonda G; Freeman ML
    Clin Cancer Res; 2011 Oct; 17(20):6490-9. PubMed ID: 21878537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro.
    Dwarakanath BS
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S27-31. PubMed ID: 20009290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed cell death associated with mitotic catastrophe in γ-irradiated stem-like glioma cells.
    Firat E; Gaedicke S; Tsurumi C; Esser N; Weyerbrock A; Niedermann G
    Radiat Oncol; 2011 Jun; 6():71. PubMed ID: 21663643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiosensitization of tumour cell lines by the polyphenol Gossypol results from depressed double-strand break repair and not from enhanced apoptosis.
    Kasten-Pisula U; Windhorst S; Dahm-Daphi J; Mayr G; Dikomey E
    Radiother Oncol; 2007 Jun; 83(3):296-303. PubMed ID: 17521756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
    Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization.
    Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ
    Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel radiosensitizing anticancer therapeutics.
    Linkous AG; Yazlovitskaya EM
    Anticancer Res; 2012 Jul; 32(7):2487-99. PubMed ID: 22753705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism.
    Dittmann KH; Mayer C; Ohneseit PA; Raju U; Andratschke NH; Milas L; Rodemann HP
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):203-12. PubMed ID: 17996386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation-Induced Cell Death: Signaling and Pharmacological Modulation.
    Philchenkov A
    Crit Rev Oncog; 2018; 23(1-2):13-37. PubMed ID: 29953366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. YU238259 Is a Novel Inhibitor of Homology-Dependent DNA Repair That Exhibits Synthetic Lethality and Radiosensitization in Repair-Deficient Tumors.
    Stachelek GC; Peterson-Roth E; Liu Y; Fernandez RJ; Pike LR; Qian JM; Abriola L; Hoyer D; Hungerford W; Merkel J; Glazer PM
    Mol Cancer Res; 2015 Oct; 13(10):1389-97. PubMed ID: 26116172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of radiosensitization by halogenated pyrimidines: effect of BrdU on cell killing and interphase chromosome breakage in radiation-sensitive cells.
    Iliakis G; Pantelias G; Kurtzman S
    Radiat Res; 1991 Jan; 125(1):56-64. PubMed ID: 1986401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of caffeine on radiation-induced mitotic inhibition in S-180 ascites tumor cells.
    Boynton AL; Evans TC; Crouse DA
    Radiat Res; 1974 Oct; 60(1):89-97. PubMed ID: 10881702
    [No Abstract]   [Full Text] [Related]  

  • 40. Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.
    Farhood B; Goradel NH; Mortezaee K; Khanlarkhani N; Salehi E; Nashtaei MS; Mirtavoos-Mahyari H; Motevaseli E; Shabeeb D; Musa AE; Najafi M
    Clin Transl Oncol; 2019 Mar; 21(3):268-279. PubMed ID: 30136132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.